SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 55.08-2.9%Dec 26 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (1380)8/4/2000 2:10:19 AM
From: Dave K  Read Replies (1) of 52153
 
Peter, thanks for sharing your valuation skills. You have an interesting angle and I'm with you until...

"One then looks at what the market is presently capitalizing such drugs at (perhaps 15x to 20x sales) and figure out what the market cap attributable to the drug will be at peak"

Where do you find a breakdown of market cap attributable to an individual drug ? Relatively easy if you're looking at a company with only one such drug with sales but not so when the sales are derived from multiple drugs. Maybe an example could illustrate ?

Thanks

Dave
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News